Recent Synthetic Approaches towards Small Molecule Reactivators of p53

Area of Science:

• Molecular Biology
• Oncology
• Drug Discovery

Background:

• The tumor suppressor protein p53, known as the "genome guardian", regulates cell cycle, DNA integrity, and apoptosis.
• Mutations in the TP53 gene inactivate p53 in about 50% of human cancers, often leading to therapy resistance.
• Restoring p53 function is a key strategy in cancer treatment research.

Purpose of the Study:

• To review current approaches for activating and reactivating the tumor suppressor function of p53.
• To focus on synthetic strategies for developing small molecules that restore p53 activity.

Main Methods:

• Literature review of synthetic approaches for p53 reactivation.
• Analysis of small molecule development and preparation methods.

Main Results:

• Identification of various synthetic strategies aimed at restoring p53 tumor suppressor function.
• Overview of small molecules designed to activate or reactivate p53.

Conclusions:

• Synthetic approaches are central to developing novel therapeutics targeting p53.
• Restoring p53 function holds significant promise for overcoming cancer therapy resistance.